Adjusted β coefficients for glycemic marker mean levels comparing African-Americans with whites among individuals with and without diagnosed diabetes, the Coronary Artery Risk Development in Young Adults study 2005–2006
| Diagnosed diabetes | No diagnosed diabetes | |||||
|---|---|---|---|---|---|---|
| Glycemic marker | African-American versus White | p Value | Model R2 | African-American versus White | p Value | Model R2 |
| Fasting glucose (mg/dL) | ||||||
| Model 1 | –3.79 (–29.89 to 22.31) | 0.775 | 0.04 | 1.05 (–0.22 to 2.31) | 0.106 | 0.03 |
| Model 2 | –3.13 (–30.71 to 24.44) | 0.823 | 0.19 | –0.35 (–1.62 to 0.93) | 0.594 | 0.14 |
| Model 3 | – | – | – | –1.06 (–2.04 to –0.08) | 0.033 | 0.39 |
| A1c (%) | ||||||
| Model 1 | 0.24 (–0.54 to 1.01) | 0.548 | 0.02 | 0.24 (0.19 to 0.29) | <0.001 | 0.06 |
| Model 2 | 0.17 (–0.64 to 0.97) | 0.684 | 0.20 | 0.19 (0.14 to 0.24) | <0.001 | 0.15 |
| Model 3 | – | – | – | 0.19 (0.15 to 0.23) | <0.001 | 0.45 |
| Glycated albumin (%) | ||||||
| Model 1 | 0.82 (–1.65 to 3.29) | 0.512 | 0.02 | 0.74 (0.60 to 0.88) | <0.001 | 0.05 |
| Model 2 | 0.60 (–1.95 to 3.15) | 0.642 | 0.20 | 0.82 (0.68 to 0.97) | <0.001 | 0.09 |
| Model 3 | – | – | – | 0.79 (0.68 to 0.91) | <0.001 | 0.38 |
| Fructosamine (μmol/L) | ||||||
| Model 1 | 8.47 (–22.31 to 39.24) | 0.587 | 0.03 | 6.60 (4.61 to 8.60) | <0.001 | 0.03 |
| Model 2 | 11.85 (–19.73 to 43.43) | 0.459 | 0.22 | 8.68 (6.68 to 10.68) | <0.001 | 0.16 |
| Model 3 | – | – | – | 8.29 (6.60 to 9.99) | <0.001 | 0.40 |
| 1,5-Anhydroglucitol (μg/mL) | ||||||
| Model 1 | 0.17 (–2.73 to 3.06) | 0.910 | 0.03 | –0.22 (–0.71 to 0.26) | 0.368 | 0.11 |
| Model 2 | 0.15 (–2.98 to 3.27) | 0.927 | 0.14 | –0.49 (–1.01 to 0.02) | 0.062 | 0.14 |
| Model 3 | – | – | – | –0.36 (–0.91 to 0.18) | 0.189 | 0.17 |
| 2-hour postchallenge glucose* (mg/dL) | ||||||
| Model 1 | – | – | – | 7.80 (4.45 to 11.14) | <0.001 | 0.02 |
| Model 2 | – | – | – | 3.50 (0.10 to 6.90) | 0.044 | 0.13 |
| Model 3 | – | – | – | 4.18 (1.29 to 7.07) | 0.005 | 0.37 |
Model 1 adjusted for age, sex, and education. Model 2 adjusted for Model 1 variables plus study field center, smoking status, body mass index, systolic blood pressure, use of antihypertensive medications, total cholesterol, HDL cholesterol, and use of lipid-lowering medications. Model 3 adjusted for model 2 variables plus 2-hour glucose (for markers other than 2-hour glucose) and fasting glucose (for markers other than fasting glucose).
*N=2164 for those without diabetes.